CSWM
IBB icon

Cassady Schiller Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Cassady Schiller Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$1.59K Hold
12
– – ﹤0.01% 647
2024
Q3 		$1.75K Hold
12
– – ﹤0.01% 398
2024
Q2 		$1.65K Hold
12
– – ﹤0.01% 405
2024
Q1 		$1.65K Buy
+12
New +$1.64K ﹤0.01% 429

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cassady Schiller Wealth Management's IBB Position: Q4 2024 in Review

Cassady Schiller Wealth Management held its iShares Biotechnology ETF (IBB) position steady in Q4 2024 at 12 shares worth $1.59K. The position accounts for ﹤0.01% of the portfolio, ranked #647.

Cassady Schiller Wealth Management first reported a position in IBB in Q1 2024 and has held it in 4 quarters since. The position peaked at $1.75K in Q3 2024. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

  • Cassady Schiller Wealth Management held 12 shares of iShares Biotechnology ETF worth $1.59K as of Q4 2024.
  • Cassady Schiller Wealth Management left its iShares Biotechnology ETF share count unchanged in Q4 2024.
  • iShares Biotechnology ETF made up ﹤0.01% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #647 holding.
  • Cassady Schiller Wealth Management first reported a position in iShares Biotechnology ETF in Q1 2024 and has held it in 4 quarters since.
  • Cassady Schiller Wealth Management's iShares Biotechnology ETF position peaked at $1.75K in Q3 2024.
  • 874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.